Structure-Activity and Structure-Degradation Relationship Studies of 2-Amino-6-(benzimidazol-2-ylmethyl)-N9-heteroarylpurines as Potent and Selective CDK12/13 Inhibitors and Cyclin K Degraders.
Journal of medicinal chemistry
View this publicationJournal of medicinal chemistry
View this publicationNature communications
View this publicationAmerican journal of human genetics
View this publicationCell stem cell
View this publicationLeukemia
View this publicationCirculation. Cardiovascular interventions
View this publicationCell death & disease
View this publicationScientific reports
View this publicationMethods in enzymology
View this publicationCell metabolism
View this publication